ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,755
-0,93%
Bitcoin
69 539,82
-2,67%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Advanced Accelerator Applications S.A. ADS (delisted) (AAAP)

  7. Advanced Accelerator Applications S.A. ADS (delisted) (AAAP) Actualités

AAAP

ADVANCED ACCELERATOR APPLICATION (AAAP)

Advanced Accelerator Applications S.A. ADS (delisted)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AAAP
DateHeureSourceTitreSymboleSociété
26/02/201920h06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
03/12/201809h00GlobeNewswire Inc.Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and c...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
12/02/201815h18Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
12/02/201813h00GlobeNewswire Inc.Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
09/02/201819h09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201822h24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201822h24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201822h24Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201822h21Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201822h05GlobeNewswire Inc.Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender OfferNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
01/02/201815h02Edgar (US Regulatory)(25)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
26/01/201818h00GlobeNewswire Inc.Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendoc...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
22/01/201814h00GlobeNewswire Inc.Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender OfferNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
07/12/201713h16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
07/12/201713h00GlobeNewswire Inc.Advanced Accelerator Applications Announces Commencement of Novartis Tender OfferNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
07/12/201712h05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
05/12/201722h20Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
05/12/201722h00GlobeNewswire Inc.Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by NovartisNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
24/11/201712h01Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
17/11/201713h39GlobeNewswire Inc.Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
31/10/201700h46Dow Jones NewsADRs End Mostly Higher; Advanced Accelerator Applications, Braskem Trade ActivelyNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201714h00Dow Jones NewsNovartis to Pay $3.9 Billion for Radio-Pharmaceuticals Firm -- UpdateNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201708h08Dow Jones NewsNovartis to Buy Advanced Accelerator Applications for $3.9 BillionNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
30/10/201707h00GlobeNewswire Inc.Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by NovartisNASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
29/09/201715h16GlobeNewswire Inc.Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera®) for Gastroenter...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
06/09/201717h03GlobeNewswire Inc.CORRECTING and REPLACING -- Advanced Accelerator Applications S.A.NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
06/09/201713h00GlobeNewswire Inc.Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lute...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
31/08/201713h00GlobeNewswire Inc.Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
28/08/201716h08GlobeNewswire Inc.Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium...NASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
27/07/201713h00GlobeNewswire Inc.Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDANASDAQ:AAAPAdvanced Accelerator Applications S.A. ADS (delisted)
 Showing the most relevant articles for your search:NASDAQ:AAAP

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
EU
RNO
Renault
NYSE
DIS
Walt Disney
EU
DG
Vinci
EU
ORA
Orange
NASDAQ
NVDA
NVIDIA
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
EU
ACA
Credit Agricole
EU
EN
Bouygues
EU
CAP
Capgemini
EU
BN
Danone
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés